Bacteroides dorei

Last updated • 4 min readFrom Wikipedia, The Free Encyclopedia

Bacteroides dorei
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Bacteroidota
Class: Bacteroidia
Order: Bacteroidales
Family: Bacteroidaceae
Genus: Bacteroides
Species:
B. dorei
Binomial name
Bacteroides dorei
Bakir et al. 2006

Bacteroides dorei is a species of bacteria within the genus Bacteroides , first isolated in 2006. It is found in the intestinal systems of humans and animals. [1] Research is being conducted to better understand the relationship Bacteroides dorei has on the human intestinal system and the autoimmune disease, Type 1 Diabetes (T1D). [1] [2]

Contents

Biology and ecology

Bacteroides dorei is a gram negative, rod-shaped bacteria that contributes to normal intestinal functionality. It was isolated and differentiated from Bacteroides vulgatus by using 16S rRNA sequencing and phenotypic tests. [3] B. dorei is a non-spore-forming, non-motile, and anaerobic bacterium with a DNA G+C content of 43%. Growth occurs optimally at 37 °C with individual cell size between 1.6-4.2 μm by 0.8-1.2 μm. In addition, colonies streaked on Eggerth Gagnon (EG) agar with 5% horse blood plate and incubated over 48 hours in 100% CO2 gas at 37 °C, resulted in colony size of 2.0 mm and individual colony morphology of circular, white, raised, and convexed. [1]

Taxonomy

Bacteroides
79
94
76
51
97
94
100
100

B. dorei 175T (=JCM 13471T) (AB242142)

B. dorei 219 (=JCM 13472) (AB242143)

B. vulgatus ATCC 8482T (M58762)

B. massiliensis CCUG 48901T (AY126616)

99

B. coprocola JCM 12979T (AB200224)

B. plebeius JCM 12973T (AB200217)

B. helcogenes JCM 6297T (AB200227)

57

B.eggerthii NCTC 11155T (L16485)

B. stercoris ATCC 43183T (X83953)

B. uniformis ATCC 8492T (L16486)

B. intestinalis JCM 13265T (AB214328)

89
78

B. nordii ATCC BAA-998T (AY608697)

B. salyersiae ATCC BAA-997T (AY608696)

B. fragilis ATCC 25285T (M11656)

B.thetaiotaomicron ATCC 29148T (L16489)

B.finegoldii JCM 13345T (AB222699)

B.ovatus NCTC 11153T (L16484)

92

B. acidifaciens JCM 10556T (AB021164)

B. caccae ATCC 43185T (XB3951)

100

B. tectus JCM 10003T (AB200228)

99

B. pyogenes JCM 6294T (AB200229)

B. denticanum B78 (AF319778)

B. coprosuis CCUG 50528T (AF319778)

100

B. merdae ATCC 43184T (X83954)

B. distasonis ATCC 8503T (M86695)

100

B. capillosus ATCC 29799T (AY136666)

B. cellulosolvens ATCC 35603T (L35517)

Provotella melaninogenica ATCC 25845T (AY323525)

Neighbour-joining tree showing phylogenetic positions of isolates 175T and 219 among recognized members of the genus Bacteroides based on 16S rRNA gene sequences available in the DDBJ/EMBL/GenBank databases. Scale bar represents 0.02 substitutions per nucleotide position. Bootstrap values (>50%) based on 1000 replications are listed as percentages at the branching points. [1]

Metabolism

Bacteroides dorei has been tested for numerous different metabolic test looking at different sugars. Growth of cells was seen via production of acid occurred on the following sugars: glucose, sucrose, xylose, rhamnose, lactose, maltose, arabinose, mannose and raffinose while no growth and no acid production occurred on the following sugars: cellobiose, salicin, trehalose, mannitol, glycerol, melezitose and sorbitol. [1]

Medical significance

Previous research has shown that individuals who are genetically predisposed to various autoimmune diseases have significant differences in bacteria composition than non-genetically predisposed individuals. This difference in bacteria composition in the gut system is increasingly believed to be highly important in understanding autoimmune diseases such as Type1 Diabetes. In 2014, researchers looked at the early development of bacterial composition in high genetic risk children looking at early onset of Type 1 Diabetes. They took stool samples of 76 children looking at the early development of microbial communities from 4–6 months of age until 2.2 year old. Out of the 76 infants, 29 seroconverted to T1D autoimmune related cases, of which of 22 later on developed T1D (cases). The other 47 infants didn't seroconvert or develop T1D (control). Metagenomic sequencing results showed significantly higher composition of B. dorei and Bacteroides vulgatus in the cases versus the control group prior to seroconversion. In addition, data showed that B. dorei peaked at 7.6 months, almost 8 months prior to first inslet autoantibody in cases. This significant compositional change suggests that the increase in amount of B. dorei is a potential indicator of the development of T1D. [2]

Additional research looked at epigenetics of B. dorei and were able to demonstrate that 1 individual had B. dorei with GATC (gene) methylation while another individual had B. dorei lacking GATC methylation. Scientist took stool samples of two babies and sequenced the genomes of B. dorei in samples 105 and 439. Sample B. dorei 105 had 49,007 total methylation in the genome with 14,322 methylation sites and in sample B. dorei 439, there was 38,203 total methylations with 24,770 methylation sites. The key result is that sample 105 includes a key gene called DamMT (DNA methyltransferase) while sample 439 lacked this gene. In addition, out of 20,554 GATC sites in sample B. dorei 105, there was only had 3 sites that weren't methylated whereas sample B. dorei 439 had 18,908 GATC sites and none of the GATC sites were methylated. Dam methylation and methylation of GATC could be significant factors for microbial colonization and functionality in the gut system and affects numerous gene expressions of transport processes such as nutrient transportation, antibiotic effluxes actions to antibiotic resistance, and movement of energy. The results suggests that Dam and GATC methylation of B. dorei 105 could have highly significant varied gene expression from B. dorei 439 that lacks GATC methylation and could affect functionality of B. dorei in the gut microbiome. Previous research has shown that Dam methylation mutants have increased susceptibility to higher antibiotic concentrations and lower minimum. This suggests that Dam methylation process plays a significant role in up-regulation of antibiotic effluxes, resulting in increased antibiotic resistance. Also, GATC methylation demonstrates important microbial functions such as DNA repair, replication, and LPS composition. Methylation of GATC motif by DamMT in pathogenic bacteria, for example, Vibrio cholerae, Yersinia pestis, and Yersinia pseudotuberculosis has been shown to increase virulence and expression of genes towards multiple operations such as, mismatch repair and DNA replication enables pathogenic bacteria to combat against antibiotics. These results show why future research to create antibiotics that prevent the creation of DamMT in pathogenetic bacteria is needed. [4]

Related Research Articles

<span class="mw-page-title-main">Human microbiome</span> Microorganisms in or on human skin and biofluids

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Though micro-animals can also live on the human body, they are typically excluded from this definition. In the context of genomics, the term human microbiome is sometimes used to refer to the collective genomes of resident microorganisms; however, the term human metagenome has the same meaning.

In medicine, the hygiene hypothesis states that early childhood exposure to particular microorganisms protects against allergies by strengthening the immune system. In particular, a lack of such exposure is thought to lead to poor immune tolerance. The time period for exposure begins before birth and ends at school age.

<span class="mw-page-title-main">Gut microbiota</span> Community of microorganisms in the gut

Gut microbiota, gut microbiome, or gut flora, are the microorganisms, including bacteria, archaea, fungi, and viruses, that live in the digestive tracts of animals. The gastrointestinal metagenome is the aggregate of all the genomes of the gut microbiota. The gut is the main location of the human microbiome. The gut microbiota has broad impacts, including effects on colonization, resistance to pathogens, maintaining the intestinal epithelium, metabolizing dietary and pharmaceutical compounds, controlling immune function, and even behavior through the gut–brain axis.

<i>Bacteroides</i> Genus of bacteria

Bacteroides is a genus of Gram-negative, obligate anaerobic bacteria. Bacteroides species are non endospore-forming bacilli, and may be either motile or nonmotile, depending on the species. The DNA base composition is 40–48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

<i>Bacteroides fragilis</i> Species of bacterium

Bacteroides fragilis is an anaerobic, Gram-negative, pleomorphic to rod-shaped bacterium. It is part of the normal microbiota of the human colon and is generally commensal, but can cause infection if displaced into the bloodstream or surrounding tissue following surgery, disease, or trauma.

Dysbiosis is characterized by a disruption to the microbiome resulting in an imbalance in the microbiota, changes in their functional composition and metabolic activities, or a shift in their local distribution. For example, a part of the human microbiota such as the skin flora, gut flora, or vaginal flora, can become deranged, with normally dominating species underrepresented and normally outcompeted or contained species increasing to fill the void. Dysbiosis is most commonly reported as a condition in the gastrointestinal tract.

<span class="mw-page-title-main">Microbial symbiosis and immunity</span>

Long-term close-knit interactions between symbiotic microbes and their host can alter host immune system responses to other microorganisms, including pathogens, and are required to maintain proper homeostasis. The immune system is a host defense system consisting of anatomical physical barriers as well as physiological and cellular responses, which protect the host against harmful microorganisms while limiting host responses to harmless symbionts. Humans are home to 1013 to 1014 bacteria, roughly equivalent to the number of human cells, and while these bacteria can be pathogenic to their host most of them are mutually beneficial to both the host and bacteria.

<span class="mw-page-title-main">Microbiota</span> Community of microorganisms

Microbiota are the range of microorganisms that may be commensal, mutualistic, or pathogenic found in and on all multicellular organisms, including plants. Microbiota include bacteria, archaea, protists, fungi, and viruses, and have been found to be crucial for immunologic, hormonal, and metabolic homeostasis of their host.

<i>Porphyromonas</i> Genus of bacteria

Porphyromonas is a Gram-negative, non-spore-forming, obligately anaerobic and non-motile genus from the family Porphyromonadaceae. There were 16 different Porphyromonas species documented as of 2015, which reside in both animal and human reservoirs. It was discovered more recently that Porphyromonas also exist in the environment, albeit to a lesser extent. This genus is notably implicated in the modulation of oral cavity, respiratory tract, and gastrointestinal tract disease states. It is suggested that Porphyromonas either operate as benign bacteria pertinent to host immunity or are potential pathobionts that opportunistically provoke diseased states when homeostasis is disrupted. Despite its characterization not being fully elucidated due to sparse research, various studies report the prevalence of this genus at 58.7% in healthy states compared with 41.3% in diseased states.

Metaproteomics is an umbrella term for experimental approaches to study all proteins in microbial communities and microbiomes from environmental sources. Metaproteomics is used to classify experiments that deal with all proteins identified and quantified from complex microbial communities. Metaproteomics approaches are comparable to gene-centric environmental genomics, or metagenomics.

An enterotype is a classification of living organisms based on the bacteriological composition of their gut microbiota. The discovery of three human enterotypes was announced in the April 2011 issue of Nature by Peer Bork and his associates. They found that enterotypes are not dictated by age, gender, body weight, or national divisions. There are indications that long-term diet influences enterotype. Type 1 is characterized by high levels of Bacteroides, type 2 has few Bacteroides but Prevotella are common, and type 3 has high levels of Ruminococcus.

The altered Schaedler flora (ASF) is a community of eight bacterial species: two lactobacilli, one Bacteroides, one spiral bacterium of the Flexistipes genus, and four extremely oxygen sensitive (EOS) fusiform-shaped species. The bacteria are selected for their dominance and persistence in the normal microflora of mice, and for their ability to be isolated and grown in laboratory settings. Germ-free animals, mainly mice, are colonized with ASF for the purpose of studying the gastrointestinal (GI) tract. Intestinal mutualistic bacteria play an important role in affecting gene expression of the GI tract, immune responses, nutrient absorption, and pathogen resistance. The standardized microbial cocktail enabled the controlled study of microbe and host interactions, role of microbes, pathogen effects, and intestinal immunity and disease association, such as cancer, inflammatory bowel disease, diabetes, and other inflammatory or autoimmune diseases. Also, compared to germfree animals, ASF mice have fully developed immune system, resistance to opportunistic pathogens, and normal GI function and health, and are a great representation of normal mice.

Sarkis Mazmanian is an American medical microbiologist who has served as a professor at the California Institute of Technology since 2006. He is currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering, and a board member of Seed. Prior to this, Mazmanian was affiliated with Harvard Medical School and the University of Chicago. In 2012, Mazmanian was awarded a MacArthur Fellowship for his pioneering work on the human microbiome.

The microbiota are the sum of all symbiotic microorganisms living on or in an organism. The fruit fly Drosophila melanogaster is a model organism and known as one of the most investigated organisms worldwide. The microbiota in flies is less complex than that found in humans. It still has an influence on the fitness of the fly, and it affects different life-history characteristics such as lifespan, resistance against pathogens (immunity) and metabolic processes (digestion). Considering the comprehensive toolkit available for research in Drosophila, analysis of its microbiome could enhance our understanding of similar processes in other types of host-microbiota interactions, including those involving humans. Microbiota plays key roles in the intestinal immune and metabolic responses via their fermentation product, acetate.

<span class="mw-page-title-main">Pharmacomicrobiomics</span>

Pharmacomicrobiomics, proposed by Prof. Marco Candela for the ERC-2009-StG project call, and publicly coined for the first time in 2010 by Rizkallah et al., is defined as the effect of microbiome variations on drug disposition, action, and toxicity. Pharmacomicrobiomics is concerned with the interaction between xenobiotics, or foreign compounds, and the gut microbiome. It is estimated that over 100 trillion prokaryotes representing more than 1000 species reside in the gut. Within the gut, microbes help modulate developmental, immunological and nutrition host functions. The aggregate genome of microbes extends the metabolic capabilities of humans, allowing them to capture nutrients from diverse sources. Namely, through the secretion of enzymes that assist in the metabolism of chemicals foreign to the body, modification of liver and intestinal enzymes, and modulation of the expression of human metabolic genes, microbes can significantly impact the ingestion of xenobiotics.

<span class="mw-page-title-main">Human milk microbiome</span> Community of microorganisms in human milk

The human milk microbiota, also known as human milk probiotics (HMP), refers to the microbiota (community of microorganisms) residing in the human mammary glands and breast milk. Human breast milk has been traditionally assumed to be sterile, but more recently both microbial culture and culture-independent techniques have confirmed that human milk contains diverse communities of bacteria which are distinct from other microbial communities inhabiting the human body.

<i>Bacteroides thetaiotaomicron</i> Species of bacterium

Bacteroides thetaiotaomicron is a gram-negative, rod shaped obligate anaerobic bacterium that is a prominent member of the normal gut microbiome in the distal intestines. Its proteome, consisting of 4,779 members, includes a system for obtaining and breaking down dietary polysaccharides that would otherwise be difficult to digest. B. thetaiotaomicron is also an opportunistic pathogen, meaning it may become virulent in immunocompromised individuals. It is often used in research as a model organism for functional studies of the human microbiota.

<span class="mw-page-title-main">Abigail A. Salyers</span> American microbiologist

Abigail A. Salyers was a microbiologist who pioneered the field of human microbiome research. Her work on the bacterial phylum Bacteroidetes and its ecology led to a better understanding of antibiotic resistance and mobile genetic elements. At a time where the prevailing paradigm was focused on E. coli as a model organism, Salyers emphasized the importance of investigating the breadth of microbial diversity. She was one of the first to conceptualize the human body as a microbial ecosystem. Over the course of her 40-year career, she was presented with numerous awards for teaching and research and an honorary degree from ETH Zurich, and served as president of the American Society for Microbiology.

<span class="mw-page-title-main">Cetacean microbiome</span>

The cetacean microbiome is the group of communities of microorganisms that reside within whales.

<i>Phocaeicola vulgatus</i> Species of bacteria

Phocaeicola vulgatus,, is a mutualistic anaerobic Gram negative rod bacteria commonly found in the human gut microbiome and isolated from feces. P. vulgatus has medical relevance and has been notable in scientific research due to its production of fatty acids, potential use as a probiotic, and associations with protecting against and worsening some inflammatory diseases. Due to the difficulties in culturing anaerobic bacteria, P. vulgatus is still highly uncharacterised so efforts are being made to make use of multi-omic approaches to investigate the human gut microbiome more thoroughly in hopes to fully understand the role of this species in the development of and protection against diseases, as well as its potential uses in medicine and research. Generally, P. vulgatus is considered as a beneficial bacteria that contributes to digestion and a balanced microbiome, but it has been known to cause opportunistic infections and induce or worsen inflammatory responses. Due to its abundance in the microbiome, some researchers are investigating these species in hopes that it will be a suitable model organism for gut microbiome research, like Bacteroides thetaiotaomicron.

References

  1. 1 2 3 4 5 Bakir, M.A.; Sakamoto, M.; Kitahara, M.; Matsumoto, M.; Benno, Y. (2006). "Bacteroides dorei gen., sp. nov., isolated from human faeces". International Journal of Systematic and Evolutionary Microbiology. 56 (7): 1639–1643. doi: 10.1099/ijs.0.64257-0 . ISSN   1466-5026. PMID   16825642.
  2. 1 2 Davis Richardson, A.G.; Ardissone, A.N.; Dias, R.; Simell, V.; Leonard, M.T.; Kemppainen, K.M.; Drew, J.C. (2014). "Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes". Frontiers in Microbiology. 5 (678): 1–11. doi: 10.3389/fmicb.2014.00678 . ISSN   1664-302X. PMC   4261809 . PMID   25540641.
  3. Pedersen, R.M.; Marmolin, E.S.; Justesen, U.S. (2013). "Species differentiation of Bacteroides dorei from Bacteroides vulgatus and Bacteroides ovatus from Bacteroides xylanisolvens–Back to basics". Anaerobe. 24 (December): 1–3. doi:10.1016/j.anaerobe.2013.08.004. ISSN   1075-9964. PMID   23994205.
  4. Leonard, M.T.; Davis-Richardson, A.G.; Ardissone, A.N.; Kemppainen, K.M.; Drew, J.C.; Ilonen, J.; Knip, M.; Simell, O.; Toppari, J.; Veijola, R.; Hyöty, H.; Triplett, E.W. (2014). "The methylome of the gut microbiome: disparate Dam methylation patterns in intestinal Bacteroides dorei". Frontiers in Microbiology. 5: 361. doi: 10.3389/fmicb.2014.00361 . ISSN   1664-302X. PMC   4101878 . PMID   25101067.